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a b s t r a c t
Medicinal tablets have been used for a long time to treat cardiovascular disease. However,
mortality rate is steadily increasing partly because of the patients’ sedentary lifestyle and
unhealthy diet. By contrast, exercise has been systematically shown to have multiple bene-
ﬁts. Regular exercise training can prevent various diseases in healthy individuals. Combined
exercise and cardiac medications may lead to the improvement of heart disease. Numer-
ous exercise training pathways still need further investigations. How exercise can prevent,eywords:
ardiac medication
xercise
treat, or attenuate diseases remains somewhat elusive. Thus, this reviewwill discuss cardiac
medications in parallel with the mechanism of action of exercise.
© 2013 Korea Institute of Oriental Medicine. Published by Elsevier. This is an open access
article under the CC BY-NC-ND license
cians. Exercise is beneﬁcial for the heart in a number of ways,eart disease
. Introduction
xercise training has been recognized to prevent and ame-
iorate cardiovascular disease. Although exercise can reduce
ardiovascular disease, it is also suggested that it can be
nstrumental in preventing chronic disease such as hyperten-
ion, dyslipidemia, and diabetes mellitus. A recent study by
ann andRosenzweig1 wonderfully highlighted the beneﬁcial
ffects of exercise including cardiac effects and systemic fac-
ors on skeletalmuscle,metabolism, and vascular dysfunction
Fig. 1).
The key role of the cardiovascular system, which is com-
osed of the heart and the intricate network of veins and
rteries throughout the body, is the transportation of vital sub-
tances. Modern-day technological advancements brought us
ase and convenience, allowing us to accomplish more at a
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faster rate, but they also translated to less physical activity. As
a consequence, diseases have also evolved and some of them
involve the cardiovascular system; for example, ischemia is
the leading cause of death as reported by the World Health
Organization based on the 2008 statistics.2 Increase in corre-
lation between cardiac disorders and diabetes is also prevalent
due to a similar contributing factor—sedentary lifestyle.3
Medications for the treatment and rehabilitation of cardiac
diseases are continually being developed. Despite the effec-
tiveness of medicines, a chemical ingested may still bring
harm to vital parts of the body as speciﬁed by their respec-
tive adverse effects. Accordingly, a natural activity such as
exercise is advised andadvocated by sports trainers andphysi-e, Cardiovascular and Metabolic Disease Center, Inje University,
although the exact process as to how exercise intervenes in
the cardiovascular system is unknown. As advised, walking by
stairs is more beneﬁcial than taking the elevator. This review
vier. This is an open access article under the CC BY-NC-ND license
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Fig. 1 – Overview of the systemic and cardiac-speciﬁc effects of exercise. Endurance exercise has multiple systemic effects,
ranging from increased skeletal muscle growth to vascular remodeling and improved energetics. Exercise also exerts direct
effects on the heart itself, including increased cardiac growth, protection against ischemic damage, and modulation of
cardiac function, metabolism, and vascular supply. AMPK, AMP-activated kinase; C/EBP , CCAAT/enhancer binding protein
; CITED4, cbp/p300-interacting trans-activator with Glu/Asprich carboxy-terminal domain 4; eNOS, endothelial nitric oxide
synthase; IGF-1, insulin-like growth factor-1; MSTN, myostatin; Nrg1, neuregulin1; PGC-1, peroxisome proliferator
activated receptor gamma co-activator 1 ; PI3K, phosphoinositide kinase-3; Pim1, proto-oncogene serine/threonine-protein
kinase-1; PLB, phospholamban; SERCA2a, sarco/endoplasmic reticulum Ca2+-ATPase, 2a; and VEGF, vascular endothelial
growth factor. Reprinted with permission form Mann et al.1
will focus on current heart medication categories commonly
used to treat diseases. Particular exercise pathways similar
or different from medications work of action will also be dis-
cussed.
2. Anticoagulant
Thrombogenesis is the formation of blood clots to prevent
excessive hemorrhage. Coagulation is a homeostatic pro-
cess that primarily involves the platelets followed by protein
clotting factors. To eliminate the formed thrombus, natural
anticoagulants exist such as protein C, which stops the clot-
ting process, followed by ﬁbrinolysis, in which the thrombus is
dissolved thus preventing dislodgement. Anticoagulant drugs
are medicines used for cardiovascular diseases (CVDs) such as
acute coronary syndromes, and they work by inhibiting one of
the clotting factors or mimicking natural anticoagulants.4
Exercise simultaneously increases coagulation and ﬁbri-
nolysis without altering the balance between them. It is
suggested to increase coagulation in the blood by an eleva-
tion in factor VIII, an important blood clotting protein, and
to balance this equation by increasing ﬁbrinolysis through
the release of more tissue type plasminogen activator (t-
PA) and limiting plasminogen activator inhibitor.5 In another
endurance exercise study, changes in conditions with tread-
mill running less than 2hours below the individual anaerobicthreshold resulted in improved ﬁbrinolysiswith reduced coag-
ulation in healthy men.6 Hypoxic training induced increased
thrombin activity with opposing effect from normoxic and
relative hypoxic trained individuals.7 Interestingly, this dif-
ference in result, an inverse proportion of ﬁbrinolysis with
thrombin formation, although both favoring exercise, relates
to the ﬂexibility of exercise outcome with changes in its com-
ponents. Short-term exercise in healthy individuals balanced
the increase in coagulation by increasing ﬁbrinolysis, whereas
in individuals with CVD it triggered an ischemic condition
with the increase in plasminogen activator inhibitor.7 Chronic
aerobic exercise, by contrast, constitutively decreased coagu-
lation and increased ﬁbrinolysis in patients with CVDs and
normal individuals.8
In CVDs, although acute exercise can negatively affect the
case, beneﬁt of endurance exercise are manifested. Change in
exercise intensity caused a change in outcome (e.g., moderate
exercise increased ﬁbrinolysis) whereas strenuous exercise
greatly affected coagulation, both without interruption in
homeostasis in healthy individuals.36 The intensity and time
of exercise in a normal individual do not alter the sustenance
of coagulation and ﬁbrinolysis balance. The combination
of thrombin inhibitors and exercise augments ﬁbrinolysis
caused by exercise without counteracting exercise-induced
platelet or leukocyte activation.9 This shows an effective way
to boost the drug’s potential. Although exercise promises a
positive effect, risk is present with individuals undergoing
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ehabilitation because of the probability of emboli. Studies
egarding the most effective exercise method and factors are
till to be uncovered.
. Antiplatelet
latelet activity is involved in the coagulation process as
he ﬁrst step in preventing hemorrhage. Antiplatelet drugs
essen the interaction of platelets to aggregate, thus prevent-
ng thrombus. The effect of exercise in platelets remains
ontroversial until today.10 Less disagreements arise from
atients with coronary heart disease where exercise boosted
p platelet number, aggregation, and function.10–12 Platelet
unction was also increased with a single bout of aerobic
xercise, 13 whereas reduced platelet count associated with
xercise was found as one of the factors to decrease cardio-
ascular risk.14–16 In sickle cell anemia, exercise decreases
latelet aggregation, giving a late, positive beneﬁt.17 These
eports indicate the need to evaluate platelet function focus-
ng on the age of the population as well as the disease
ondition and exercise parameters. Differences in method-
logy make it difﬁcult to derive a deﬁnite conclusion on the
irect or indirect effect of exercise to platelet. Also, the dura-
ion of increased platelet after exercise is unknown. Further
nvestigation is also warranted to differentiate the impact of
xercise on platelet between genders. Aspirin, which is one
f the frequently used antiplatelet agents, does not attenuate
he exercise-induced increase in platelet aggregation.10–12
. Angiotensin II receptor blockers
he regulation of internal circulation of blood and ﬂuids is
andled by the renin–angiotensin system (RAS), governed by
ormones controlling the decrease inwater balance and blood
ressure. This systemic process involves the kidneys that
ecrete the renin after the detection of low blood pressure.
enin stimulates the transformation of angiotensinogen in
he liver into angiotensin I (Ang I) that is further transformed
nto angiotensin II (Ang II) by the angiotensin-converting
nzyme (ACE) from the lungs. This hormone, in turn,
rompts aldosterone release from the adrenal cortex, relay-
ng to the kidneys information to compensate for the loss.
nvolvement of this process is observed in pathological left
entricular hypertrophy, which occurs in certain conditions
uch as myocardial infarct (MI) and heart failure (HF). The
ction of angiotensin receptor blockers is the inhibition of
ng II (the main hormone during the process acting as a
asoconstrictor).18 The prevention of veins from narrowing
ecreases the potential of increase in blood pressure. Exercise
s reported to inﬂuence the RAS.19,20
Acute exercise was associated with elevations in plasma
ldosterone, renin activity, potassium, and vasopressin.21,22
enerally, renin plasma level is increased after a period of
xercise, activatingmoreAng I andAng II overtaking renin lev-
ls due to lactic acidosis, which inhibits angiotensinases.19,23
ngiotensin receptor 1 (ATr1) decreased by Ang II leads
o unfavorable cardiac remodeling.24 In the normal heart,
ng II was decreased after aerobic exercise accompanied by51
increased angiotensin receptor 2 (ATr2); similarly, ATr2 eleva-
tion in exercised HF condition is associated with vasodilation,
stimulating nitric oxide and bradykinin.20,22 In contrast to
this result, ATr1 protein as well as ACE binding decreased in
response to exercise in MI rats.25 Decline in ATr1 was con-
stituted with inhibition of Ang II binding, thereby resulting
in favorable reduced ﬁbrosis formation. Aerobic exercise also
increased ACE2 and decreased cardiac AngII and ACE in obese
rats.26
5. ACE inhibitors
The target of the ACE inhibitors is the ACE, which mediates
in the conversion of Ang I into Ang II. ACE inhibition leads to
a decrease in Ang II, ﬁnally lowering blood pressure. In the
serum, ACE increases in response to acute exercise indepen-
dent of ACE genotype, which is correlated with elevation in
cardiac ACE thus elevated Ang II.27–29 A study revealed that
ACE majorly contributes to Ang II formation in the heart.27
ACE’s importance is portrayed with its gene insertion and
deletion polymorphism that is associated with MI, cardiomy-
opathy, left ventricular hypertrophy, coronary artery disease,
and HF.28,30 ACE was observed to elevate in the early develop-
ment of myocardial dysfunction with a potential contribution
in ventricular remodeling.31 Post-MI exercise treatment can
decrease ACE, attenuating the pathological remodeling.25
ACE2 is anACE homolog that is unresponsive to ACE inhibitors
and reported to have a cardioprotective role. Adding up to
the RAS pathway, ACE2 hydrolyzes Ang I, resulting to Ang-
(1–9), which is in turn transformed into Ang-(1–7) by a neutral
endopeptidase and ACE.32,33 ACE2 is a vasodilator activating
Ang (1–7) releasing vasofactors, a contradictory mechanism
from ACE balancing the latter. ACE levels do not directly
contribute to left ventricular hypertrophy; however, increase
in ACE2—as reﬂected in exercise—attenuates left ventricu-
lar hypertrophy by decreasing angiotensin II and increasing
expression of angiotensin (1–7).20 Chronic inhibition of ACE2
in transgenic hypertensive rats elevates angiotensin II in the
heart that resulted in ﬁbrosis and pathological hypertrophy.23
In relation to neurophysiology, animal models from young
to old age exhibited improvement in memory with exercise. In
humans, increased physical activity was reported to decrease
the chance of acquiring dementia.34 ACE inhibitors are known
to have positive impact on the cognition of animals and people
withHF,whichmay be associatedwith the blockage of AngII.35
6. Beta blockers
Tissues that respond to sympathetic stimulation contain beta
adrenoceptors, which are the binding sites of catecholamine.
Predominantly in the heart, the most abundant among the
three distinct types of adrenoceptors with highest function-
ality are the 1 adrenoceptors.36 In the heart, 1 are localized
on large conduit coronary arteries,whereas2 are dispersed in
the small arteries and arterioles. On a cellular basis, 1 reside
in the cell membrane, whereas 2 are secluded in the cave-
olae. Beta-blockers prevent the normal ligand from binding
to the beta-adrenoceptor by competing for the binding site.
The inhibition of epinephrine and norepinephrine results in
52
lower blood pressure with slower heart rate and less cardiac
output. The sympathetic activity produced by these receptors
depends on their expression, distribution, and responsiveness
to catecholamine.
Exercise affects catecholamine regulation as well as the
distribution of adrenoceptors. Generally, exercise stimulates
epinephrine and norepinephrine increase in the serum.36
Coronary vessels respond with signiﬁcant elevation in left
ventricular norepinephrine secretion and epinephrine usage.
This sympathetic response of both receptors increases heart
rate, contractility, and a -adrenoceptor-mediated coronary
vasodilation.36 The norepinephrine binding with 1 is mostly
responsible for the coronary vasodilation and partially by 2
and epinephrine binding.36
A disproportion in this constituent leads to predictable
responses. The initial course of HF is accompanied by
compensatory expression catecholamine. Chronically, it pro-
gresses to a higher 2/1 ratio, which ﬁnally results to
improper calcium handling contributing to arrhythmias.37,38
Exercise reverses this outcome by increasing the respon-
siveness to 1 adrenoreceptor and decreasing sympathetic
activation.38 Also, a recovery of beta adrenergic signaling
pathway was achieved via equilibrating the 2/1 ratio after
exercise in dogs susceptible for ventricular ﬁbrillation.39
Acute voluntary wheel models maintained 1 expression with
a decline in 2 regulation and function rehabilitating HF
models.38
Diabetic heart comes along with bradycardia and car-
diomyopathy because of decreased responsiveness with beta
adrenoceptors responsible for the sympathetic activities.40
Different models of exercise contribute to multiple alter-
ations in adrenoceptor response. Intensive exercises effect
on normal rats reﬂects diabetic adrenoceptor effects such as
1 down-regulation decreasing positive inotropy and 3 up-
regulation improving negative inotropy. In addition, intense
exercise accompanies decreased 2 adrenoceptor, inhibition
of 1 loss without restoration, and normalized 3 as opposed
to 1 restorationwith 2 normalization and 3 upregulation in
moderate exercise. Intensive exercise in diabetic rats accen-
tuates bradycardia by rendering less sympathetic response,
although it remains unknown whether it provides cardio-
protection against arrhythmias.41 3’s impact in the heart
still needs to be further studied with its chronotropic effect
remaining as a controversial topic.
Exercise alters the distribution of receptors as well as reg-
ulating the catecholamine that bind with them. Therefore,
the beneﬁts surpass the normal mechanism as it greatly con-
tributes to cardiometabolic disorders.
7. Calcium channel blockers
Calcium ions in the heart are factors responsible for smooth
muscle contraction. Systole depends on the accumulation of
calcium in the cytoplasm and diastole proceeds upon the
extrusion of calcium. The amount and pooling duration of
cytoplasmic calcium determines the force of contractility of
the myocytes. Active transport of calcium extracellularly to
the cell is mediated by voltage-gated calcium channels. Cal-
cium channel blockers (CCBs) interrupt calcium transpositionIntegr Med Res ( 2 0 1 3 ) 49–55
by binding to the channels such as the l-type calcium chan-
nels in the heart and in smooth muscle of the peripheral
vasculature promoting vasodilation of peripheral vasculature
and coronary arteries excluding veins, thus a decrease in
cardiac contractility and output. However, there are irreg-
ularities with the relationship of CCBs and mortality rate.
Womenwith hypertensionwithout CVDhistorywere reported
to have a higher mortality rate than those who took beta
blockers with diuretics,56 whereas patients at risk for CVD
undergoing hemodialysis and hypertensive end-stage renal
disease patients showed a lower mortality rate with CCB
treatment.42,43
Exercise has systemic outcome to calcium balance in mul-
tiple organs in the body. It is well known how exercise
strengthens bones and prevents calcium loss especially in
lactating women.44 Aside from voltage-gated channels, cal-
cium homeostasis in cells is mediated by protein pathways.
A review highlighted multiple proteins involved in myocyte
calcium handling speciﬁcally related to cardiac hypertrophy
andexercise effect.50 In themyocytes, proteinsmainly respon-
sible for calcium handling regulated by exercise are cardiac
sarcoplasmic reticulum calcium-ATPase (SERCA2a), cardiac
sodium/calcium exchanger (NCX1), and ryanodine receptor
2 (RyR2). All three proteins take part in systole and diastole
of the heart with SERCAa2 contributing the most with relax-
ation. Disturbance in the balance of these proteins was seen
with failing hearts, where SERCA2a was downregulated and
NCX was increased.45,46 Long-term aerobic exercise in animal
models with HF resulted in restored abnormality in calcium
handling proteins.45–48
8. Statins
Statins are inhibitors of HMG-CoA reductase that are enzymes
involved in cholesterol formation in the liver. High levels of
cholesterol, speciﬁcally low-density lipoproteins (LDLs), are
elevated in most CVDs leading to viscous blood and plaque
buildup potentiating atherosclerosis. Therefore, limiting this
level will prevent damage to the heart.
Exercise can lower cholesterol by burning and using it
as an energy source. Exercise is related with both improved
muscle function and heart strength, whereas the opposite
was observed with sedentary living.49 Obese and over-
weight men who have increased lipids and LDLs were found
to have better prognosis against diseases when treated
with aerobic muscular conditioning.50 Also, a new protein,
irisin, which is induced by exercise, was found to turn
white adipose tissue to brown, such as adipose tissue, and
has decreased expression in sedentary diabetic and obese
individuals.51
Statin therapy is safe for reducing cholesterol levels with
few cases of adverse effects.52 However, precaution is needed
regarding the use of statins and exercise together. Reports
about statin affecting muscle strength are evident, although
53,54a deeper investigation is needed. However, in patients
with coronary arterial diseases, statin combined with exercise
appeared to be beneﬁcial in attenuating arterial wall stiffness
and increasing high-density lipoproteins.55,56
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Fig. 2 – Exercise effect on cardiac medication. Epi, epinephrine; NE, norephinephrine; DM, diabetes mellitus; AngII,
angiotensin 2; ATr1, angiotensin receptor 1; ATr2, angiotensin receptor 2; ACE, angiotensin converting enzyme; MI,
myocardial infarction; HDL, high density lipoprotein; NCX, Na+/Ca+ exchanger; RyR2, ryanodine recepter2; HF, heart failure;
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. Concluding remarks and future
erspectives
an’s increasing propensity toward obesity is a threat that
oses high risk because it could lead to heart problems. Aware-
ess of the outcome of a sedentary lifestyle offers a better
nderstanding of the ways that we can combat this problem.
romotion of programs providing more information about the
erits of exercise therapy to high risk populations should
e adopted. Medications are continually being developed,
ith the aim of preserving and serving as cardioprotective
gents. However, a pill for exercise remains unavailable to
ate—exercise coupled with proper nutrition still serves as
he best option to prevent diseases as well as to have a healthy
eart able to resist future threats.
Multiple ﬁndings showcase how beneﬁcial exercise is to
ealthy individuals and thosewith various diseases.Moderate
xercise done regularly produces cardioprotection.57 Although
0minutes was said to sufﬁce as weekly exercise to improve
ealth, conﬂicts about its intensity, duration, and timing still
eed be resolved.58 Exercise serves as cardiac medication
hat works at the cellular level to balance proper signaling
olecules. Although interaction between exercise and medi-
ations has been reported, further investigations are needed
o explain how acute and chronic exercises exert their bene-
cial effects. Molecular studies in exercise might lead to the
evelopment of drug(s) that can alter somepathways and thus
revent diseases.
This review highlighted the ways in which exercise pro-
ides positive contributions to various “conditions”; however,
t is also apparent that much information is still needed before
e can “see” the whole picture. Exercise deﬁnitely provides
ardioprotection, although the main mechanism it targets isyet to be unveiled. Further research is needed to establish the
proper exercise settings needed for particular diseases.
The integration of medicine and exercise is beneﬁcial in
some cases and can be detrimental in other situations (Fig. 2).
The resulting adverse effects should be further studied in
depth.
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